To evaluate Cerberus as Nodal inhibitor in human breast cancers, we examined by Western blotting Nodal expression in several human breast cancer cell lines that exhibit different invasive properties in vitro and in vivo, including MDA-MB-231, BT-549, Hs578t, and MCF-7. Here, NODAL is linked to breast cancer.